IFPA Gábor Than Award Lecture: Recognition of placental failure is key to saving babies' lives. (April 2015)

• Record Type: Journal Article
• Authors: Heazell, A.E.P.; Worton, S.A.; Higgins, L.E.; Ingram, E.; Johnstone, E.D.; Jones, R.L.; Sibley, C.P.
• Is Part Of: Placenta. Volume 36:Supplement 1(2015:)
• Page Start: S20
• Page End: S28
• Publication Date: 2015-04
• Subjects: Stillbirth -- Perinatal death -- Fetal growth restriction -- Placental insufficiency -- Placental dysfunction; Placenta -- Periodicals; Reproduction -- Periodicals; Placenta -- Periodicals; Placenta -- Périodiques; Reproduction -- Périodiques; 612.63
• DOI: 10.1016/j.placenta.2014.12.017
• Languages: English
• ISSNs: 0143-4004

Abstract

Abstract: In high-income countries, placental failure is implicated in up to 65% of cases of stillbirth. Placental failure describes the situation where the placenta cannot meet the fetus' needs and may be the end-result of a variety of underlying pathological processes evident in the placental disc, membranes and umbilical cord. These include lesions with genetic, environmental, infectious, inflammatory, mechanical, metabolic, traumatic or vascular origin. Investigation of placental tissue from stillbirths and from pregnancies at an increased risk of stillbirth has demonstrated changes in macroscopic and microscopic structure which are themselves related to abnormal placental function. A better understanding and identification of placental failure may improve the management of pregnancy complications and of pregnancies after stillbirth (which have a 5-fold increased risk of stillbirth). The majority of current antenatal tests focus on the fetus and its response to the intrauterine environment; few of these investigations reduce stillbirths in low-risk pregnancies. However, some currently used investigations reflect placental development, structure and vascular function, while other investigations employed in clinical research settings such as the evaluation of placental structure and shape have a good predictive value for adverse fetal outcome. In addition, recent studies suggest that biomarkers of placental inflammation and deteriorating placental function can be detected in maternal blood suggesting that holistic evaluation of placental structure and function is possible. We anticipate that development of reliable tests of placental structure and function, coupled to assessment of fetal wellbeing offer a new opportunity to identify pregnancies at risk of stillbirth and to direct novel therapeutic strategies to prevent it.